| Year |
Citation |
Score |
| 2023 |
Zhou JJ, Cho JS, Han H, Blitz IL, Wang W, Cho KWY. Histone deacetylase 1 maintains lineage integrity through histone acetylome refinement during early embryogenesis. Elife. 12. PMID 36971347 DOI: 10.7554/eLife.79380 |
0.302 |
|
| 2015 |
Roulois D, Loo Yau H, Singhania R, Wang Y, Danesh A, Shen SY, Han H, Liang G, Jones PA, Pugh TJ, O'Brien C, De Carvalho DD. DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts. Cell. 162: 961-73. PMID 26317465 DOI: 10.1016/J.Cell.2015.07.056 |
0.506 |
|
| 2014 |
Yang X, Han H, De Carvalho DD, Lay FD, Jones PA, Liang G. Gene body methylation can alter gene expression and is a therapeutic target in cancer. Cancer Cell. 26: 577-90. PMID 25263941 DOI: 10.1016/J.Ccr.2014.07.028 |
0.561 |
|
| 2013 |
Han H, Yang X, Pandiyan K, Liang G. Synergistic re-activation of epigenetically silenced genes by combinatorial inhibition of DNMTs and LSD1 in cancer cells. Plos One. 8: e75136. PMID 24040395 DOI: 10.1371/Journal.Pone.0075136 |
0.5 |
|
| 2013 |
Liang G, Han H, Carvalho DDD, Yang X, Jones PA. Abstract 677: Transient exposure to decitabine results in sustained cell growth inhibition and long term DNA demethylation at specific loci. Cancer Research. 73: 677-677. DOI: 10.1158/1538-7445.Am2013-677 |
0.605 |
|
| 2013 |
Yang X, Han H, Treppendahl MB, Tsai YC, O'Connell C, Weisenberger D, Lay F, Grønbæk K, Liang G, Jones PA. Abstract 4624: Identification of novel DNA methylation markers to track patient's response to DNA demethylation agents. Cancer Research. 73: 4624-4624. DOI: 10.1158/1538-7445.Am2013-4624 |
0.586 |
|
| 2012 |
Han H, Wolff EM, Liang G. Epigenetic alterations in bladder cancer and their potential clinical implications. Advances in Urology. 2012: 546917. PMID 22829811 DOI: 10.1155/2012/546917 |
0.6 |
|
| 2012 |
Yang X, Noushmehr H, Han H, Andreu-Vieyra C, Liang G, Jones PA. Gene reactivation by 5-aza-2'-deoxycytidine-induced demethylation requires SRCAP-mediated H2A.Z insertion to establish nucleosome depleted regions. Plos Genetics. 8: e1002604. PMID 22479200 DOI: 10.1371/Journal.Pgen.1002604 |
0.606 |
|
| 2012 |
Sharma S, Gerke DS, Han HF, Jeong S, Stallcup MR, Jones PA, Liang G. Lysine methyltransferase G9a is not required for DNMT3A/3B anchoring to methylated nucleosomes and maintenance of DNA methylation in somatic cells. Epigenetics & Chromatin. 5: 3. PMID 22284370 DOI: 10.1186/1756-8935-5-3 |
0.617 |
|
| 2011 |
Han H, Cortez CC, Yang X, Nichols PW, Jones PA, Liang G. DNA methylation directly silences genes with non-CpG island promoters and establishes a nucleosome occupied promoter. Human Molecular Genetics. 20: 4299-310. PMID 21835883 DOI: 10.1093/Hmg/Ddr356 |
0.709 |
|
| 2010 |
Yang X, Lay F, Han H, Jones PA. Targeting DNA methylation for epigenetic therapy. Trends in Pharmacological Sciences. 31: 536-46. PMID 20846732 DOI: 10.1016/J.Tips.2010.08.001 |
0.587 |
|
| 2010 |
Wolff EM, Byun HM, Han HF, Sharma S, Nichols PW, Siegmund KD, Yang AS, Jones PA, Liang G. Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer. Plos Genetics. 6: e1000917. PMID 20421991 DOI: 10.1371/Journal.Pgen.1000917 |
0.649 |
|
| 2009 |
Jeong S, Liang G, Sharma S, Lin JC, Choi SH, Han H, Yoo CB, Egger G, Yang AS, Jones PA. Selective anchoring of DNA methyltransferases 3A and 3B to nucleosomes containing methylated DNA. Molecular and Cellular Biology. 29: 5366-76. PMID 19620278 DOI: 10.1128/Mcb.00484-09 |
0.694 |
|
| Show low-probability matches. |